Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice
Dasatinib and Quercetin (D+Q), a senolytic drug combination, effectively slowed age-related disc degeneration in mice when administered before the onset of established degeneration. D+Q reduced senescence markers, mitigated inflammation, and preserved disc matrix composition, indicating its potential as a therapeutic strategy for early- to mid-stage disc degeneration.